Cancer Metabolomics

Based on gene expression and DNA grouping, cancer genomics controls how the contrast between tumour cells and regular cells is portrayed. The goal of this inquiry is to better understand the fundamental hereditary characteristics of tumour progression, the alteration of the disease's genome, and the role of treatment in the cancer microenvironment. The study of the chemical traces a metabolite leaves behind during digestion is known as metabolomics. Examining the metabolite profile for sedative improvement in the event of the presence of tumour cells will be of the utmost importance. One of the many discoveries in disease metabolomics is the noninvasive validation of metabolic biomarkers from the bodily fluid of tumour patients.

    Related Conference of Cancer Metabolomics

    August 20-21, 2024

    11th World Summit on Epilepsy and Bipolar Disorders

    Montreal, Canada
    September 26-27, 2024

    7th Annual Congress on Emergency Medicine and Acute Care

    Amsterdam, Netherlands
    October 14-15, 2024

    11th World Machine Learning and Deep learning Conference

    Barcelona, Spain
    October 31-01, 2024

    8th International Conference on Internal Medicine

    Amsterdam, Netherlands
    November 22-23, 2024

    4th International Conference on Medical Research and Development

    Aix-en-Provence, France
    November 25-26, 2024

    10th World Congress on Anesthesia and Critical Care

    Aix-en-Provence, France

    Cancer Metabolomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in